ProCE Banner Activity

Recent Progress With CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice


Download these slides from an interdisciplinary team workshop series on the latest updates with integrating CD38-targeted antibodies into the treatment of patients with multiple myeloma

Released: October 25, 2023



Ajai Chari

Ajai Chari, MD

Director of Multiple Myeloma Program
Professor of Clinical Medicine
University of California- San Francisco
San Francisco, California

Saad Z. Usmani

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College, Cornell University
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Sanofi.